Race and the histologic grade of prostate cancer

Prostate

Volumn 30, Issue 2, 1997, Pages 79-84

  Freeman, Vincent L ^a   Leszczak, Jaroslaw ^a   Cooper, Richard S ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

blacks; histology; mortality; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CARCINOMA; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CHICAGO; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS;

EID: 0031020089     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970201)30:2<79::AID-PROS2>3.0.CO;2-F     Document Type: Article

References (33)

1. Nomura AMY, Kolonel LN: Prostate cancer: A current perspective. Epidemiol Rev 13:200-227, 1991.
2. Wingo PA, Tong T, Bolden S: Cancer Statistics. CA 45:8-30, 1995.
3. Reis LA, Miller BA, Hankey BF, Edwards BK (eds): "SEER Cancer Statistics Review, 1973-91: Tables and Graphs," NIH Publ No. 94-2789. Bethesda, MD: NCI, 1994.
4. Burks DA, Littleton RH: The epidemiology of prostate cancer in black men. Henry Ford Hosp Med J 40:89-92, 1992.
5. Dayal HH, Polissar L, Dahlberg S: Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J Natl Cancer Inst 74:1001-1006, 1985.
6. Foster CS, McLoughlin J, Bashir I, Abel PD: Markers of the metastatic phenotype in prostate cancer. Hum Pathol 23:381-394, 1992.
7. Mellinger GT, Gleason DF, Bailar J: The histology and prognosis of prostatic cancer. J Urol 111:58-64, 1974.
8. Epstein JI, Pizov G, Walsh PC: Correlation of pathologic findings with progression following radical prostatectomy. Cancer 71:3582-3593, 1993.
9. Polednak AP, Flannery JT: Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 70:2152-2158, 1992.
10. Brawn PN, Johnson EH, Kuhl DL, Riggs MW, Speights VO, Johnson CF, Pandya PP, Lind ML, Bell NF: Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 71:2569-2573, 1993.
11. Kim JA, Kuban DA, El-Mahdi AM, Schellhammer PF: Carcinoma of the prostate: Race as a prognostic indicator in definitive radiation therapy. Radiology 194:545-549, 1995.
12. Lawton CA, Cantrell JE, Derus SW, Murray KJ, Byhardt RW, Wilson JF: Prostate cancer: Are racial differences in clinical stage and survival explained by differences in symptoms? Radiology 192:37-40, 1994.
13. Hussain F, Aziz H, Macchia RG, Avitable M, Rotman M: High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean island immigrants. Int J Radiat Oncol Biol Phys 24:451-461, 1992.
14. American Cancer Society: "Cancer in Illinois: 1991. An Incidence Report by 11 Hospitals." Chicago: American Cancer Society, 1993, pp 28-32.
15. Illinois Department of Public Health, Division of Epidemiologic Studies: Cancer incidence in Illinois by County 1986-1990. Epidemiol Rep Series 92:4, 1992.
16. 1990 Census of Population: "Social and Economic Characteristics." U.S. Department of Commerce, Economies and Statistics Administration. Bureau of the Census, Publication no. 1990 CP-2-1.
17. Stamey TA, McNeal JE: Adenomacarcinoma of the prostate. In Walsh PC (ed): "Campbell's Urology," 6th ed. Philadelphia: W.B. Saunders Company, 1992, pp 1159-1221.
18. Borek D, Butcher D, Hassanein K, Holmes F: Relationship of age to histologie grade in prostate cancer. Prostate 16:305-311, 1990.
19. Gleason DF: Histologic grade, clinical stage, and patient age in prostate cancer. NCI Mongr 7:15-18, 1988.
20. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 2:719-748, 1959.
21. Miettinen OS: Estimability and estimation in case-referent studies. Am J Epidemiol 103:226-235, 1976.
22. Breslow NE, Day NE: "Statistical Methods in Cancer Research," Vol 1. Lyon: IARC, 1980, pp 142-143.
23. Natarajan N, Murphy GP, Mettlin C: Prostate cancer in blacks: An update from the American College of Surgeons' patterns of care studies. J Surg Oncol 40:232-263, 1989.
24. Harada M, Mostofi FK, Corle DK, Byar DD, Trump BF: Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61:223-225, 1977.
25. Gleason DF: Histologic grading of prostate cancer: A perspective. Hum Pathol 23:273-279, 1992.
26. Carter HB, Piantadosi S, Issacs JT: Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 143:742, 1990.
27. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC: A prospective study of dietar fat and risk of prostate cancer. J Natl Cancer Inst 85:311-316, 1993.
28. West DW, Slattery MLI, Robinson LM, French TC, Mahoney AW: Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive rumors. Cancer Causes Control 2:85-94, 1991.
29. Haenszel W, Kurihara M: Studies of Japanese migrants: I. Mortality from cancer and other diseases among Japanese in the U.S. J Natl Cancer Inst 40:43-68, 1968.
30. Akazaki K, Stermmerman GN: Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaiians. J Natl Cancer Inst 50:1137-1144, 1973.
31. Staszewski J, Haenszel W: Cancer mortality among the Polish born in the U.S. J Natl Cancer Inst 35:291-297, 1965.
32. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh C-Z, Stamey T: Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141:732-740, 1995.
33. Huncharek M, Muscat J: Genetic characteristics of prostate cancer. Cancer Epidemiol Biomarkers Prev 4:681-687, 1995.